Hyperfine (HYPR) Deferred Taxes (2021 - 2026)
Hyperfine (HYPR) posted Deferred Taxes of -$457000.0 for Q1 2026, down 193.08% on a QoQ basis from $491000.0 in Q4 2025, and down 210.65% year-over-year from $413000.0 in Q1 2025.
Hyperfine (HYPR) Deferred Taxes (2021 - 2026) Analysis & Trends
Hyperfine's Deferred Taxes history runs 6 years deep, the most recent figure standing at -$457000.0 for Q1 2026.
- Quarterly Deferred Taxes fell 210.65% year-over-year to -$457000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $59000.0 (down 86.62% YoY) and the FY2025 annual result came in at $929000.0, up 256.66% from the prior year.
- Deferred Taxes was -$457000.0 for Q1 2026 at Hyperfine, down from $491000.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $491000.0 in Q4 2025 and bottomed at -$679000.0 in Q1 2022.
- A 5-year average of -$133437.5 and a median of -$237000.0 in 2024 frame the typical range for Deferred Taxes.
- Annual changes were most pronounced in 2024 — Deferred Taxes slumped 970.69% — and 2025, when it jumped 357.07%.
- Hyperfine's Deferred Taxes stood at -$488000.0 in 2022, then surged by 114.96% to $73000.0 in 2023, then slumped by 361.64% to -$191000.0 in 2024, then soared by 357.07% to $491000.0 in 2025, then tumbled by 193.08% to -$457000.0 in 2026.
- Business Quant data shows HYPR's Deferred Taxes at -$457000.0 in Q1 2026, $491000.0 in Q4 2025, and $308000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.32 Bn | 177.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn | -33.00 Mn |
| 3 | Medtronic | 108.88 Bn | 99.66 Bn | 6.41 Bn | -8.00 Mn |
| 4 | Boston Scientific | 68.65 Bn | 67.20 Bn | 3.61 Bn | -351.00 Mn |
| 5 | Edwards Lifesciences | 47.43 Bn | 43.76 Bn | 1.29 Bn | -9.40 Mn |
| 6 | GE HealthCare Technologies | 28.48 Bn | 26.19 Bn | 1.98 Bn | - |
| 7 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn | 7.30 Mn |
| 8 | Smith & Nephew | 26.98 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn | 51.51 Mn |
| 10 | Hyperfine | 93.92 Mn | 52.65 Mn | 1.98 Mn | -457,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -457,000.00 |
| Dec 31, 2025 | 491,000.00 |
| Sep 30, 2025 | 308,000.00 |
| Jun 30, 2025 | -283,000.00 |
| Mar 31, 2025 | 413,000.00 |
| Dec 31, 2024 | -191,000.00 |
| Sep 30, 2024 | 219,000.00 |
| Mar 31, 2024 | -621,000.00 |
| Dec 31, 2023 | 73,000.00 |
| Sep 30, 2023 | -394,000.00 |
| Jun 30, 2023 | 256,000.00 |
| Mar 31, 2023 | -58,000.00 |
| Dec 31, 2022 | -488,000.00 |
| Sep 30, 2022 | -345,000.00 |
| Jun 30, 2022 | -379,000.00 |
| Mar 31, 2022 | -679,000.00 |
| Dec 31, 2021 | -805,000.00 |
| Sep 30, 2021 | 2.18 Mn |